3801 - 3825 of 9148 Results
Title
Year
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 71
- Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative2026RESTRICTEDTitle: Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78249Citation Count: 0
-
OPENTitle: Feasibility of Virtual Research Visits in Fox Trial FinderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 505End Page: 515Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150549Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150549?id=journal-of-parkinsons-disease%2Fjpd150549Citation Count: 64
-
OPENTitle: Overcoming obstacles to repurposing for neurodegenerative diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 1Issue #: 7Start Page: 512End Page: 518Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.76Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.76Citation Count: 62
-
OPENTitle: A Culturally Tailored Community Health Worker Intervention Leads to Improvement in Patient-Centered Outcomes for Immigrant Patients With Type 2 DiabetesJournal Name: Clinical DiabetesPublisher: American Diabetes AssociationVol: 36Issue #: 2Start Page: 100End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2337/cd17-0068Best OA location URL: https://clinical.diabetesjournals.org/content/diaclin/36/2/100.full.pdfCitation Count: 61
- Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease2026RESTRICTEDTitle: Recruitment Strategies across the Spectrum of Neuronal Synuclein DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78239Citation Count: 0
-
OPENTitle: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In VivoJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 148Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/59758Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10337163/pdf/nihms-1911472.pdfCitation Count: 56
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 52
-
OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 57
-
OPENTitle: Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin studyJournal Name: Journal of NeurochemistryPublisher: WileyVol: 149Issue #: 1Start Page: 126End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/jnc.14569Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14569Citation Count: 56
- Real-World Experience With VMAT2 Inhibitors2019RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 50
-
OPENTitle: Differential protein–protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathwaysJournal Name: Journal of NeurochemistryPublisher: WileyVol: 131Issue #: 2Start Page: 239End Page: 250Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12798Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12798?download=trueCitation Count: 52
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 84
- Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD)2018RESTRICTEDTitle: Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD)Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 70Issue #:Start Page: 242End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.06.029Citation Count: 17
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015OPENTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9927027Citation Count: 56
-
OPENTitle: Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?Journal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 139Issue #:Start Page: 244End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2015.10.019Best OA location URL: http://doi.org/10.1016/j.clineuro.2015.10.019Citation Count: 13
-
OPENTitle: Defining α-synuclein species responsible for Parkinson’s disease phenotypes in miceJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 294Issue #: 27Start Page: 10392End Page: 10406Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra119.007743Best OA location URL: http://www.jbc.org/article/S0021925820318330/pdfCitation Count: 133
-
OPENTitle: Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 8Start Page: 2105End Page: 2111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.6b00217Best OA location URL: http://doi.org/10.1021/acschembio.6b00217Citation Count: 87
-
OPENTitle: Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 85End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.022Best OA location URL: http://www.prd-journal.com/article/S1353802019300227/pdfCitation Count: 99
-
OPENTitle: Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think TankJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page: 734End Page: 734Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00734Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00734/pdfCitation Count: 77
- Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain2014OPENTitle: Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrainJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1110End Page: 1120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.047Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.07.047Citation Count: 22
- Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats2011RESTRICTEDTitle: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 1052End Page: 1061Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016Citation Count: 24
-
OPENTitle: Concomitant pathologies among a spectrum of parkinsonian disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 5Start Page: 525End Page: 529Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.012Best OA location URL: http://doi.org/10.1016/j.parkreldis.2014.02.012Citation Count: 164
-
OPENTitle: Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 854End Page: 865Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29349Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29349Citation Count: 19
-
OPENTitle: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 156Issue #:Start Page: 105409End Page: 105409Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105409Citation Count: 36